selenic acid has been researched along with Prostatic Neoplasms in 3 studies
Selenic Acid: A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sodium selenate is a small, water-soluble, orally bioavailable activator of PP2A phosphatase with anti-angiogenic properties." | 2.75 | Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer. ( Corcoran, NM; Costello, AJ; Hovens, CM; Michael, M; Rosenthal, MA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corcoran, NM | 1 |
| Hovens, CM | 1 |
| Michael, M | 1 |
| Rosenthal, MA | 1 |
| Costello, AJ | 1 |
| Holmstrom, A | 1 |
| Wu, RT | 1 |
| Zeng, H | 1 |
| Lei, KY | 1 |
| Cheng, WH | 1 |
| Lipinski, B | 1 |
1 trial available for selenic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Male | 2010 |
2 other studies available for selenic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice.
Topics: Aging; Animals; Anticarcinogenic Agents; Cell Line, Tumor; Dietary Supplements; Humans; Male; Mice; | 2012 |
Re: Science peels the onion of selenium effects on prostate carcinogenesis.
Topics: Anticarcinogenic Agents; Antioxidants; Humans; Male; Oxidation-Reduction; Prostatic Neoplasms; Selen | 2004 |